课题基金 / 基金详情

SB 209763 IN CHILDREN WITH DISEASE AS TREATMENT AGAINST RSV

SB 209763 IN CHILDREN WITH DISEASE AS TREATMENT AGAINST RSV
SB 209763 用于患有 RSV 疾病的儿童的治疗
批准号：
5221319
负责人：
MARK H SAWYER
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5221319
关键词：
antibody formation chemoprevention clinical research disease /disorder prevention /control human subject human therapy evaluation infant human (0-1 year) opportunistic infections preschool child (1-5) respiratory disorder chemotherapy respiratory syncytial virus

项目摘要

项目成果

MARK H SAWYER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To evaluate safety and efficacy of multiple doses of sb 209763 in prevention of severe RSV infection in infants and young children with underlying diseases which predispose them to serious RSV infection. To evaluate the safety of multiple doses of sb 209763 and evaluate whether antibodies to the drug are formed in infants and young children given multiple IM doses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
San Diego-Influenza Coverage Extension (SD-ICE)
Impact of New Adolescent Vaccines
San Diego-Influenza Coverage Extension (SD-ICE)
Impact of New Adolescent Vaccines
海外基金